Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or Amirah Al Idrus (email | Twitter), and we will feature it here at the end of each week.
23andMe brings on Dean Schorno as CFO, operations head |
|||||||||||||||||||
23andMe named Dean Schorno as its CFO and operations head this week, a role in which he'll oversee the company's global financial and clinical laboratory operations. Schorno most recently served as CFO for Adaptive Biotechnologies, where he was responsible for all financial operations and facilities management. Prior to Adaptive, Schorno spent 13 years at Genomic Health, where he served as both vice president of operations and chief financial officer. "Dean Schorno is a world class financial executive with deep operational and category experience who will bring discipline to the complexities of our business," said Andy Page, 23andMe president. Release
|